Opinion channel feed – Endpoints News

Opinion channel feed

Time for biotechies to stand up and be counted on Kendall Square

9 years ago

Scott Gottlieb gave a savvy review of what we can expect at the FDA; When times got rough, a biotech CEO demonstrated real integrity

9 years ago

Dems fire off a silly pricing bill; What's wrong with Novartis?

9 years ago

Put away the flamethrower Mr. President. We come in peace and prosperity.

9 years ago

Trump needs to prove he's serious about science; PTC's latest move is a jaw dropper

9 years ago

Bristol-Myers makes a decisive move to fix its R&D problem; Let's not underestimate Trump now

9 years ago

The new CEOs in biopharma are joining the big players at the billion-dollar chip table

9 years ago

There has to be a better way to handle Duchenne drugs; Let's get to the bottom of the Juno debacle

9 years ago

Let's not forget why biopharma megamergers are such an awful idea

9 years ago

Another price-gouging CEO proves the system is broken, underscoring need for principled reform at the FDA

9 years ago

No, President Trump, biopharma does not want you to deregulate drug development

9 years ago

Another biotech games the system, and everyone gets to pay for the fallout

9 years ago

Vowing to help, Trump manages to spark an angry protest against policies and a plan to revamp the FDA

9 years ago

AstraZeneca chief is betting the company’s future on a single roll of the dice

9 years ago

Big Pharma CEOs get a face-to-face with Trump and a shot at a negotiated cease fire

9 years ago

M&A is off to a hot start in 2017; Too bad we can't say the same for gender parity

9 years ago

Libertarian ideas on FDA deregulation threaten biotech; It's time for some real power to reform drug prices, reasonably

9 years ago

Mallinckrodt just got its hand slapped for illegally protecting an 85,000% price hike

9 years ago

Trump nukes biopharma, and the fallout is radioactive

9 years ago

2017 gets started with a bang as we get a glimpse of the good, the bad and the ugly

9 years ago

The Senate fumbles its first stab at pharma profiteering, keeping the issue front and center in 2017

9 years ago

Big Pharma’s business model is broken; New drug OKs plunged this year, highlighting an ugly reality

9 years ago

Drug pricing remains the big issue for 2017; Let's not go down the rabbit hole at the FDA

9 years ago

Is the US biopharma industry headed for a turning point in 2017?

9 years ago

First page Previous page 5 6 789 10 Next page Last page